Thromboflex leukodepletion platelet filter

The use of leukodepletion is a major step to improve transfusion safety thanks to a significant reduction of patient adverse reactions and pathogen transmissions.

Macopharma develops and manufactures leukodepletion systems to improve the quality and the safety of blood components, allowing better patient outcome.

Please enable JavaScript in your browser to complete this form.

Download eCatalogue

A valid email is required. You will receive a link to download the eCatalogue in your mailbox.


Meet your need by giving you the flexibility to fit your Buffy Coat platelet method :

• Thromboflex TXP filter is the optimal solution for leucocyte removal from platelet concentrates prepared under Buffy Coat method

• Thromboflex TXP filter allows the filtration of a pool of 4 to 6 Buffy Coats suspended in plasma or PAS and processed until 24 hours after collection




High leukodepletion performance
THROMBOFLEX TXP provides high leukodepletion performance >4 log

Compliance with all the European guidelines parameters for Platelet concentrates


Transparent housing for visual monitoring of the filtration

Easy handling

Low filtration loss +/- 7,5 mL

Oxy-PL storage container guarantying an optimal gas permeability for optimized platelet quality


Macopharma is a major global player in the filtration of blood components, with unique know-how and expertise. We have a deep understanding of customer requirements and strive to provide users with reliable and robust filters, guarantying high performance.

This information is for exclusive use of healthcare professionals.
The products are not available in every country, please contact your sales representative.
MACOPHARMA • Rue Lorthiois 59240 Mouvaux France • Tel : + 33 (0) 3 20 11 84 00 • Fax : +33 (0) 3 20 11 84 03
Société par actions simplifiée au Capital de 493.115 € RCS Lille Metropole 391 600 905 • Code APE 4641 Z • TVA FR 313 916 009 05